Clinical translational neuroscience

Clinical translational neuroscience

Overview

This research program aims to improve our understanding of the biology of mental illness in young people. This covers brain imaging (structure, function, and chemistry), cognitive ability (memory, attention, etc), and measures derived from blood samples (such as genetics, or immune response). We also want to understand how these measures change over time, both as a result of normal development and of experiencing mental illness.

Why is this research important?

Understanding the contribution of neurobiology to the onset and persistence of mental disorders in young people will help develop new treatments, and target the ones we already have to those they are most likely to help.

Key questions

Can neurobiological measures (brain imaging, cognitive testing etc) help predict clinical outcomes? Can they do so reliably and usefully?

What role does altered adolescent brain development play in the onset of mental illness?

Collaborators

The University of Melbourne, Monash University, the PRONIA consortium, University of Birmingham, University of Manchester and the National University of Singapore.

Research Leader

Professor Stephen Wood
Head, Clinical Translational Neuroscience
Research Interests:
Neuroimaging and cognitive predictors of functional outcome, adolescent brain development, ultra high risk

Members

  • Associate Professor Lianne Schmaal
  • Dr Chris Davey
  • Dr Cali Bartholomeusz
  • Dr Meredith McHugh
  • Dr Suzie Lavoie
  • Professor Paul Amminger
  • Dr Kelly Allott
  • Dr John Gillam
  • Laura van Velzen, Research Fellow
  • Akhil Kottaram, Research Fellow
  • Pemma Davies, Research Assistant
  • Elena Pozzi, Research Assistant
  • Hannah Savage, Research Assistant
  • Yara Toenders, PhD candidate
  • Johanna Bayer, PhD candidate
  • Shaunagh O’Sullivan, PhD candidate
  • Magdalene Rose de Rozario, Master student
  • Chaira Serrarens, Master student